Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 09:40 am Sale | 13G | Sarepta Therapeutics Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 4,358,511 4.600% | -987,274 (-18.47%) | View |
| 2024-11-13 10:27 am Purchase | 13G | Sarepta Therapeutics Inc. SRPT | Capital International Investors | 6,363,590 6.700% | 1,622,105 (+34.21%) | View |
| 2024-06-07 1:30 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | BlackRock Inc. BLK | 10,124,431 10.700% | 3,857,458 (+61.55%) | View |
| 2024-02-13 5:13 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | VANGUARD GROUP INC | 8,816,124 9.420% | 782,860 (+9.75%) | View |
| 2024-02-13 1:34 pm Sale | 13G | Sarepta Therapeutics Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 5,345,785 5.700% | -682,231 (-11.32%) | View |
| 2024-02-09 6:05 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | Capital International Investors | 4,741,485 5.100% | 4,741,485 (New Position) | View |
| 2024-01-26 5:26 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | BlackRock Inc. BLK | 6,266,973 6.700% | 709,739 (+12.77%) | View |
| 2023-02-14 3:23 pm Sale | 13G | Sarepta Therapeutics Inc. SRPT | SANDS CAPITAL MANAGEMENT LLC | 2,151,378 2.500% | -3,213,249 (-59.90%) | View |
| 2023-02-10 11:28 am Sale | 13G | Sarepta Therapeutics Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 6,028,016 6.900% | -1,217,846 (-16.81%) | View |
| 2023-02-09 11:32 am Sale | 13G | Sarepta Therapeutics Inc. SRPT | VANGUARD GROUP INC | 8,033,264 9.150% | -277,844 (-3.34%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | BlackRock Inc. BLK | 5,557,234 6.300% | 272,000 (+5.15%) | View |
| 2022-02-11 7:18 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | SANDS CAPITAL MANAGEMENT LLC | 5,364,627 6.160% | 4,387,496 (+449.02%) | View |
| 2022-02-11 12:13 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 7,245,862 8.300% | 7,245,862 (New Position) | View |
| 2022-02-10 08:37 am Purchase | 13G | Sarepta Therapeutics Inc. SRPT | VANGUARD GROUP INC | 8,311,108 9.540% | 1,093,849 (+15.16%) | View |
| 2022-02-09 10:24 am Sale | 13G | Sarepta Therapeutics Inc. SRPT | FMR LLC | 2,955,056 3.391% | -3,160,172 (-51.68%) | View |
| 2022-02-01 5:14 pm Sale | 13G | Sarepta Therapeutics Inc. SRPT | BlackRock Inc. BLK | 5,285,234 6.100% | -93,981 (-1.75%) | View |
| 2021-08-10 12:21 pm Sale | 13G | Sarepta Therapeutics Inc. SRPT | Capital Research Global Investors | 3,842,491 4.800% | -4,181,639 (-52.11%) | View |
| 2021-02-16 11:40 am Sale | 13G | Sarepta Therapeutics Inc. SRPT | SANDS CAPITAL MANAGEMENT LLC | 977,131 1.240% | -3,580,368 (-78.56%) | View |
| 2021-02-10 12:30 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | Capital Research Global Investors | 8,024,130 10.200% | 287,382 (+3.71%) | View |
| 2021-02-10 12:26 pm Purchase | 13G | Sarepta Therapeutics Inc. SRPT | Capital Research Global Investors | 7,736,748 9.800% | 7,736,748 (New Position) | View |